ArticleJournal of central nervous system disease2021

Effective Early Treatment of AChR Antibody-Positive Myasthenia Gravis with Rituximab; the Experience from a Neuroimmunology Clinic in a Developing Country.

Thomas Mathew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.